Stock comparison

ABTvsUNH

Abbott LaboratoriesvsUnitedHealth Group Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

ABT

Abbott Laboratories

$91.7

-26.39%

Health Care$161.5BNYSE
UNH

UnitedHealth Group Inc

$354.56

+3.72%

Health Care$244.4BNYSE

60-day price, rebased to 100

ABT -15.89% · UNH +20.59%

Round-by-round

ABT 2·UNH 3· 1tie
EdgeUNH

Valuation upside

-14.50% vs +194.90% to DCF fair value

EdgeABT

Balance-sheet strength

Altman Z 4.61 vs 2.69

Tie

Fundamental quality

Piotroski 6.00 vs 6.00 (of 9)

EdgeABT

Growth + margins

Rule-of-40 22.40 vs 15.40

EdgeUNH

60-day momentum

-15.89% vs +20.59% price return

EdgeUNH

Market-cap liquidity

$161.5B vs $244.4B

Verdict

Across6categories,UNHtakes the edge with3wins to2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onABTorUNH

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.

For informational and educational purposes only. Not financial advice. Learn more